Careers

Diversity

With 18 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Practices & Industries

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Lee Rosebush, Marc Wagner Participate in Compounding Panel at INTERPHEX

ADventures in Law

How to End Up on Top When Claiming to Be No. 1

IP Intelligence Report

Manufacturing Matters: The USPTO’s New Discretionary Institution Factors

Data Counsel

California Privacy in 2026: Regulations, Enforcement, AI and More

Learn How Businesses in the Healthcare Industry and Other Industries Involved in Collaborations with Competitors Can Plan to Minimize Uncertainty Resulting from the Withdrawal of the FTC/DOJ Healthcare Guidelines, from the DOJ’s Civil and Criminal Task Force on Healthcare Monopolies and Collusion, and from Other Recent DOJ and FTC Actions

contentpilot/introduction

The DOJ and FTC have recently taken significant actions to increase the antitrust scrutiny of healthcare companies overall and also other businesses involved in collaborations with competitors. This CLE webinar will assess these new developments and provide a concrete plan for how to minimize the uncertainty resulting from the withdrawal of the FTC/DOJ Healthcare Guidelines, from the DOJ’s Civil and Criminal Task Force on Healthcare Monopolies and Collusion, and from other recent DOJ and FTC actions.

core/paragraph

The reasons for and the implications of the withdrawal of the Healthcare Guidelines and the announcement of the DOJ Healthcare Task Force.

core/list-item

Why there are significant implications extending beyond the healthcare industry.

A simple approach to avoiding antitrust problems in the absence of FTC/DOJ Guidelines.

How these changes have practically presented themselves in the deal context, contract negotiations, and day-to-day business strategy considerations for health plans, facilities, providers and others.

core/list

Questions? Contact Baruch Kintisch, bkintisch@bakerlaw.com

Webinar: How Healthcare Companies (and Others) Can Avoid Antitrust Issues Despite Recent DOJ and FTC Actions

Featured Insights

Related Services

Featured Insights